<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01084200</url>
  </required_header>
  <id_info>
    <org_study_id>TJHMZK01004</org_study_id>
    <nct_id>NCT01084200</nct_id>
  </id_info>
  <brief_title>Comparison of Sevoflurane, Propofol, and Sevoflurane Plus Propofol for Maintenance of Anaesthesia</brief_title>
  <official_title>Comparison of Postoperative Pain of Sevoflurane, Propofol, and Sevoflurane Plus Propofol in Maintenance of Anaesthesia for Gynaecological Laparoscopic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Huazhong University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huazhong University of Science and Technology</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative pain may be affected by general anaesthetics. The effect of propofol and
      sevoflurane on postoperative pain in chinese female patients has not been demonstrated
      before. This study compared the postoperative pain score in patients under general
      anaesthesia maintained with propofol,sevoflurane, or sevoflurane+propofol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After approval from the Institute's Ethics Committee, this study was conducted at Tongji
      Hospital, a general university teaching hospital with 2500 beds in Wuhan, China.The study
      consisted of female patients, American Society of Anaesthesiologists Physical Status (ASA-PS)
      I or II, suffering from infertilities, and undergoing selective gynaecological laparoscopic
      and hysteroscopic surgery. All the patients were randomly assigned to receive
      propofol,sevoflurane,or sevoflurane+propofol for anaesthesia maintenance. The primary outcome
      measure was the level of postoperative pain assessed by Numerical Analogue Scale (NAS) at
      rest 0.5 hour after the operation. The secondary outcomes were postoperative pain assessed by
      Numerical Analogue Scale (NAS) at rest 1 and 24 hour after the operation, the incidence of
      postoperative nausea and vomiting, the incidence of shiver, and quality of recovery
      determined by QOR40 in the first 24 h after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post operative pain determined by NRS at 0.5h after surgery</measure>
    <time_frame>at 0.5h after the surgery</time_frame>
    <description>The level of postoperative pain was assessed by Numerical Analogue Scale (NAS) at rest at 0.5 hour after the surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative delirium</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Postoperative delirium determined by Nu-DESC every 8 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PONV</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Incidence of postoperative nausea and vomiting was assessed at 24h after the surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QOR</measure>
    <time_frame>24 hours post operatively</time_frame>
    <description>Quality of recovery was determined by QOR40 at 24h after the surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative pain determined by NRS at 1h and 24h after surgery</measure>
    <time_frame>at 1h and 24h after surgery</time_frame>
    <description>Post operative pain determined by NRS at 1h and 24h after surgery respectively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of shivering in the first postoperative day.</measure>
    <time_frame>follow up at 24 h after the surgery</time_frame>
    <description>Incidence of shivering was assessed at 24h after the surgery.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Laparoscopic Surgery</condition>
  <condition>Hysteroscopic Surgery</condition>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>anesthesia maintenance with propofol and remifentanil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sevoflurane and Remifentanil for anesthesia maintenance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sevoflurane+Propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sevoflurane+Propofol for anesthesia maintenance</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol for maintenance</intervention_name>
    <description>Propofol 6-8mg/kg/h + Remifentail 0.1-0.2ug/kg/min for anesthesia maintenance</description>
    <arm_group_label>Propofol</arm_group_label>
    <other_name>Propofol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>Sevoflurane 0.7-1.3MAC + Remifentail 0.1-0.2ug/kg/min for anesthesia maintenance</description>
    <arm_group_label>Sevoflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane+Propofol</intervention_name>
    <description>Sevoflurane 0.7-1.3MAC + Remifentanil 0.1-0.2ug/kg/min + Propofol 2mg/kg/h for anesthesia maintenance</description>
    <arm_group_label>Sevoflurane+Propofol</arm_group_label>
    <other_name>Sevoflurane and Propofol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA physical status class 1 or 2

          -  Aged &gt;=18 years and =&lt;40 years old

          -  Suffering from infertilities

          -  Under elective gynaecological laparoscopic and hysteroscopic surgery

        Exclusion Criteria:

          -  ASA-PS&gt;=III

          -  Aged under 18 yrs or above 40 yrs old

          -  Body mass index (BMI) &gt;30

          -  Respiratory or Neurologic disease

          -  Chronic antidepressants and Anticonvulsant drugs

          -  Chronic analgesics intake

          -  A known allergy to the drugs being used

          -  History of substance abuse

          -  Participating in the investigation of another experimental agent

          -  Participating in the investigation of another study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei Mei, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yu Ke Tian, Prof. M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tongji Hospital, Huazhong University of Science and Technology</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Li M, Mei W, Wang P, Yu Y, Qian W, Zhang ZG, Tian YK. Propofol reduces early post-operative pain after gynecological laparoscopy. Acta Anaesthesiol Scand. 2012 Mar;56(3):368-75. doi: 10.1111/j.1399-6576.2011.02603.x. Epub 2011 Dec 23.</citation>
    <PMID>22192060</PMID>
  </results_reference>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2010</study_first_submitted>
  <study_first_submitted_qc>March 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2010</study_first_posted>
  <last_update_submitted>August 9, 2012</last_update_submitted>
  <last_update_submitted_qc>August 9, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Huazhong University of Science and Technology</investigator_affiliation>
    <investigator_full_name>Wei Mei</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Postoperative pain</keyword>
  <keyword>Sevoflurane</keyword>
  <keyword>Propofol</keyword>
  <keyword>Female</keyword>
  <keyword>Elective gynaecological surgery</keyword>
  <keyword>Laparoscopic and hysteroscopic surgery</keyword>
  <keyword>Female patients</keyword>
  <keyword>Undergoing elective laparoscopic and hysteroscopic surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

